These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 15277582)

  • 1. A novel nonpeptide antagonist of the kinin B1 receptor: effects at the rabbit receptor.
    Morissette G; Fortin JP; Otis S; Bouthillier J; Marceau F
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1121-30. PubMed ID: 15277582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
    Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
    Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
    Morissette G; Bouthillier J; Marceau F
    Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the mitogen-activated protein kinases in the expression of the kinin B1 receptors induced by tissue injury.
    Larrivée JF; Bachvarov DR; Houle F; Landry J; Huot J; Marceau F
    J Immunol; 1998 Feb; 160(3):1419-26. PubMed ID: 9570562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescent ligands of the bradykinin B1 receptors: pharmacologic characterization and application to the study of agonist-induced receptor translocation and cell surface receptor expression.
    Bawolak MT; Gera L; Morissette G; Bouthillier J; Stewart JM; Gobeil LA; Lodge R; Adam A; Marceau F
    J Pharmacol Exp Ther; 2009 Apr; 329(1):159-68. PubMed ID: 19136639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nonpeptide antagonist reveals a highly glycosylated state of the rabbit kinin B1 receptor.
    Fortin JP; Dziadulewicz EK; Gera L; Marceau F
    Mol Pharmacol; 2006 Apr; 69(4):1146-57. PubMed ID: 16407468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human and rabbit arterial smooth muscle cell migration mediated by the kinin B1 receptor: role of receptor density and released mediators.
    Morissette G; Sabourin T; Adam A; Marceau F
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1107-19. PubMed ID: 17218975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin.
    Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM
    J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization.
    Gougat J; Ferrari B; Sarran L; Planchenault C; Poncelet M; Maruani J; Alonso R; Cudennec A; Croci T; Guagnini F; Urban-Szabo K; Martinolle JP; Soubrié P; Finance O; Le Fur G
    J Pharmacol Exp Ther; 2004 May; 309(2):661-9. PubMed ID: 14747609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta.
    Fortin JP; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors.
    Levesque L; Drapeau G; Grose JH; Rioux F; Marceau F
    Br J Pharmacol; 1993 Aug; 109(4):1254-62. PubMed ID: 8104648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
    Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
    Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.
    Gera L; Fortin JP; Adam A; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of a bradykinin B1 receptor in human ileum: pharmacological comparison to the rabbit aorta B1 receptor.
    Zuzack JS; Burkard MR; Cuadrado DK; Greer RA; Selig WM; Whalley ET
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1337-43. PubMed ID: 8667195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-peptide antagonist unusually selective for the human form of the bradykinin B2 receptor.
    Marceau F; Fortin JP; Morissette G; Dziadulewicz EK
    Int Immunopharmacol; 2003 Oct; 3(10-11):1529-36. PubMed ID: 12946450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin B1 receptor expression induced by tissue damage in the rat portal vein: a critical role for mitogen-activated protein kinase and nuclear factor-kappaB signaling pathways.
    Medeiros R; Cabrini DA; Ferreira J; Fernandes ES; Mori MA; Pesquero JB; Bader M; Avellar MC; Campos MM; Calixto JB
    Circ Res; 2004 May; 94(10):1375-82. PubMed ID: 15087417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958.
    Gera L; Stewart JM; Fortin JP; Morissette G; Marceau F
    Int Immunopharmacol; 2008 Feb; 8(2):289-92. PubMed ID: 18182242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins.
    Drapeau G; Audet R; Levesque L; Godin D; Marceau F
    J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bradykinin activates R-, T-, and L-type Ca2+ channels and induces a sustained increase of nuclear Ca2+ in aortic vascular smooth muscle cells.
    Bkaily G; Jaalouk D; Jacques D; Economos D; Hassan G; Simaan M; Regoli D; Pothier P
    Can J Physiol Pharmacol; 1997 Jun; 75(6):652-60. PubMed ID: 9276144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.